Zobrazeno 1 - 10
of 30
pro vyhledávání: '"M. Luz Martínez-Chantar"'
Autor:
Rebeca Mayo, Javier Crespo, Ibon Martínez‐Arranz, Jesus M Banales, Mayte Arias, Itziar Mincholé, Rocío Aller de la Fuente, Raúl Jimenez‐Agüero, Cristina Alonso, Daniel A. de Luis, Libor Vitek, Jan Stritesky, Joan Caballería, Manuel Romero‐Gómez, Antonio Martín‐Duce, Jose Maria Mugüerza Huguet, José Ignacio Busteros‐Moraza, Michael O. Idowu, Azucena Castro, M. Luz Martínez‐Chantar, Pablo Ortiz, Radan Bruha, Shelly C. Lu, Pierre Bedossa, Mazen Noureddin, Arun J. Sanyal, José M. Mato
Publikováno v:
Hepatology Communications, Vol 2, Iss 7, Pp 807-820 (2018)
Nonalcoholic fatty liver disease (NAFLD) is the most common type of chronic liver disease worldwide and includes a broad spectrum of histologic phenotypes, ranging from simple hepatic steatosis or nonalcoholic fatty liver (NAFL) to nonalcoholic steat
Externí odkaz:
https://doaj.org/article/3db3e565d647480a965ad1c11a5f01be
Publikováno v:
Annals of Hepatology, Vol 12, Iss 2, Pp 183-189 (2013)
Methionine is an essential amino acid that is metabolized mainly by the liver where it is converted to S-adenosylmethionine (SAMe) by the enzyme methionine adenosyltransferase. Although all mammalian cells synthesize SAMe, the liver is where the bulk
Externí odkaz:
https://doaj.org/article/ade93f20c9654e05a2de7e3f99db22a8
Autor:
Arun J. Sanyal, Jan Stritesky, Antonio Martín-Duce, Shelly C. Lu, Manuel Romero-Gómez, Mayte Arias, Javier Crespo, M. Luz Martínez-Chantar, Itziar Mincholé, Pablo Ortiz, Rocio Aller-de la Fuente, Joan Caballería, Cristina Alonso, José M. Mato, Michael O. Idowu, Radan Bruha, Rebeca Mayo, José Ignacio Busteros‐Moraza, D.A. de Luis, Jesus M. Banales, Raul Jimenez-Agüero, Jose Maria Mugüerza Huguet, Ibon Martínez-Arranz, Pierre Bedossa, Mazen Noureddin, A. Castro, Libor Vítek
Publikováno v:
Repositorio Institucional de la Consejería de Sanidad de la Comunidad de Madrid
Consejería de Sanidad de la Comunidad de Madrid
Hepatology communications, vol 2, iss 7
Hepatology Communications
Addi. Archivo Digital para la Docencia y la Investigación
instname
Consejería de Sanidad de la Comunidad de Madrid
Hepatology communications, vol 2, iss 7
Hepatology Communications
Addi. Archivo Digital para la Docencia y la Investigación
instname
Nonalcoholic fatty liver disease (NAFLD) is the most common type of chronic liver disease worldwide and includes a broad spectrum of histologic phenotypes, ranging from simple hepatic steatosis or nonalcoholic fatty liver (NAFL) to nonalcoholic steat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8ac6ec5e019d7cfa87696f0c13149dec
https://hdl.handle.net/20.500.12530/43453
https://hdl.handle.net/20.500.12530/43453
Publikováno v:
Hepatology. 60:736-743
Medicine is expected to benefit from combining usual cellular and molecular studies with high-throughput methods (genomics, transcriptomics, proteomics, and metabolomics). These methods, collectively known as omics, permit the determination of thousa
Autor:
Cristina Alonso, Juan L. García-Rodríguez, Conrad Wagner, José M. Mato, Zigmund Luka, Marta Varela-Rey, Ibon Martínez-Arranz, Shelly C. Lu, Naiara Beraza, Xabier Buqué, Igor Aurrekoetxea, Larraitz Fernández-Ares, M. Luz Martínez-Chantar, Daniela Mestre, Richard H. Finnell, Maite Martínez-Uña, Ainara Cano, Patricia Aspichueta
Publikováno v:
Hepatology. 58:1296-1305
Methionine adenosyltransferase 1A (MAT1A) and glycine N-methyltransferase (GNMT) are the primary genes involved in hepatic S-adenosylmethionine (SAMe) synthesis and degradation, respectively. Mat1a ablation in mice induces a decrease in hepatic SAMe,
Autor:
Marta Benet, José V. Castell, Javier González-Gallego, Carla Guzmán, Sandra Pisonero-Vaquero, Ramiro Jover, M. Luz Martínez-Chantar, Marta Moya, Sonia Sánchez-Campos, M. Victoria García-Mediavilla
Publikováno v:
Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1831:803-818
Liver fatty acid binding protein (FABP1) prevents lipotoxicity of free fatty acids and regulates fatty acid trafficking and partition. Our objective is to investigate the transcription factors controlling the human FABP1 gene and their regulation in
Autor:
Shelly C. Lu, Ariane Menor, Juan L. García-Rodríguez, Xabier Buqué, José M. Mato, Patricia Aspichueta, M. Luz Martínez-Chantar, Begoña Ochoa, Igor Aurrekoetxea, Maite Martínez-Uña, Ainara Cano
Publikováno v:
Hepatology. 54:1975-1986
Very low-density lipoprotein (VLDL) secretion provides a mechanism to export triglycerides (TG) from the liver to peripheral tissues, maintaining lipid homeostasis. In nonalcoholic fatty liver disease (NAFLD), VLDL secretion disturbances are unclear.
Autor:
Juan José Lozano, Kwang Suk Ko, Heping Yang, Samuel W. French, Shelly C. Lu, Komal Ramani, Ainhoa Iglesias-Ara, Bangyan L. Stiles, Barbara A. French, Lina He, Tony W.H. Li, José M. Mato, M. Luz Martínez-Chantar, Maria Lauda Tomasi, Pilsoo Oh
Publikováno v:
Hepatology. 52:2096-2108
Prohibitin 1 (PHB1) is a highly conserved, ubiquitously expressed protein that participates in diverse processes including mitochondrial chaperone, growth and apoptosis. The role of PHB1 in vivo is unclear and whether it is a tumor suppressor is cont
Novel Function and Intracellular Localization of Methionine Adenosyltransferase 2β Splicing Variants
Autor:
Shelly C. Lu, Heping Yang, Ling-Chi Wang, Ebrahim Zandi, Sean Bemanian, José M. Mato, Meng Xia, M. Luz Martínez-Chantar, Yongheng Chen
Publikováno v:
Journal of Biological Chemistry. 285:20015-20021
Human methionine adenosyltransferase 2beta (MAT2beta) encodes for two major splicing variants, V1 and V2, which are differentially expressed in normal tissues. Both variants are induced in human liver cancer and positively regulate growth. The aim of
Autor:
Antonio Martín Duce, Estefanía Fernández, M. Luz Martínez-Chantar, Carolina Gómara, Eva Rodríguez-Suárez, Usue Ariz, Felix Martínez Arrieta, Felix Elortza, Nere Alkorta, Shelly C. Lu, José M. Mato, Juan Caballería
Publikováno v:
ResearcherID
Non-alcoholic fatty liver disease (NAFLD) is an important cause of chronic liver injury that has gained concern in clinical hepatology. The principal aim of this study was to find differences in protein expression between patients with NAFLD and heal